Format

Send to

Choose Destination
See comment in PubMed Commons below
J Alzheimers Dis. 2012;29(3):487-92. doi: 10.3233/JAD-2011-111928.

Hormesis and amyloid-β protein: physiology or pathology?

Author information

1
Division of Geriatric Medicine, Saint Louis University School of Medicine, St. Louis, MO, USA. morley@slu.edu

Abstract

Hormesis is the concept that low doses of a toxin can have beneficial effects while high doses are harmful. This is also known as the inverted-U shaped dose-response curve. Hormesis appears to be a universal law for the function of memory mimetics. Amyloid-β protein is widely recognized to be a toxic agent responsible for plaque formation in Alzheimer's disease. In high doses it also produces amnesia. In lower, physiological doses, it enhances long term potentiation and memory. Blocking amyloid-β protein in animals without overproduction of the protein results in amnesia. At low doses, amyloid-β also increases neurite outgrowth, produces presynaptic enhancement, and may quench oxidative damage. It is postulated that both over- and underproduction of amyloid-β can lead to memory deficits. This is similar to a number of hormonal diseases, e.g., thyroid, where both low and high levels produce disease.

PMID:
22258515
DOI:
10.3233/JAD-2011-111928
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for IOS Press
    Loading ...
    Support Center